KonferensiyaМахмудова Л.И
Хожиев Б.Б
10.5281/zenodo.20479004
Annotatsiya
Сўнгги йилларда алкоголсиз ёғли жигар касаллиги (АЁЖК) гепатобилиар тизим патологиялари орасида кенг тарқалган касалликлардан бирига айланди. Айниқса, холецистэктомиядан кейин модда алмашинуви бузилишлари ва сафро айланишининг ўзгариши жигарда стеатоз ривожланиш хавфини оширади. Шу сабабли, касалликни эрта аниқлашда замонавий лаборатор ва инструментал баҳолаш усулларини қўллаш муҳим аҳамият касб этади.
Kalit so'zlar:
Тадқиқот мақсади. Холецистэктомиядан кейин алкоголсиз ёғли жигар касаллигини аниқлашда лаборатор ва инструментал диагностика усулларининг самарадорлигини баҳолаш.
Foydalanilgan adabiyotlar
1. Anna Liu, Sukhman Brar, Kate McKenzie, Melanie Beaton, Heather Lapier, Irene Hramiak, Mayur Brahmania, Tamara Spaic, Kristin K Clemens, OR24-01 Characteristics Of Patients With Type 1 Or 2 Diabetes And Non-alcoholic Fatty Liver Disease: A Retrospective Cohort Study// Journal of the Endocrine Society. – 2023 – Т.7. – №.1. – С.114-672. 2. Arab, J. P., Arrese, M., & Trauner, M. Recent insights into the pathogenesis of nonalcoholic fatty liver disease// Annual Review of Pathology: Mechanisms of Disease. – 2018 – Т.13. – С.321-350. 3. Awad, E. A., Ali-Eldin, Z. A., Allam, A. S., & Mahmoud, M. I. (2024). Diagnostic role of Non-Invasive risk scores in prediction of simple steatosis versus// Non-Alcoholic steatohepatitis. QJM: An International Journal of Medicine. – 2024 – Т.117 – №.1.– С.270-307. 4. Badmus, O. O., Hinds Jr, T. D., & Stec, D. E. (2023). Mechanisms linking metabolic associated fatty liver disease (MAFLD) to cardiovascular disease// Current hypertension reports.– 2023 – Т.25 – №.8 – С.151-162. 5. Barrera F. et al. The Janus of a disease: Diabetes and metabolic dysfunction associated fatty liver disease//Annals of Hepatology. – 2024. – Т. 29. – №.4. – С. 101 501. 6. Bence, K. K., & Birnbaum, M. J. (2021). Metabolic drivers of non-alcoholic fatty liver disease// Molecular metabolism – 2021 – №.50. – С.101-143. 7. Boushehri YG, Meymanatabadi Z, Tanha AE, Azami P, Alaei M, Alamdari AA, Momtazi H, Moezzi ND, Habibzadeh A, Khanmohammadi S. Association of triglyceride glucose-body mass index (TyG-BMI) with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis// – 2025 – Т.4. – №.20(8). – С.324 483. 8. Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic Syndrome Pathophysiology and Predisposing Factors. Int J Sports Med. – 2021– Т.42.– №.3. – С.199-214. 9. Budd, J., & Cusi, K. Nonalcoholic fatty liver disease: what does the primary care physician need to know// The American Journal of Medicine. – 2020 – Т.133. –№.5. С.536-543. 10. Byrne C D, Patel J, Scorletti E, Targher G. Tests for diagnosing and monitoring non alcoholic fatty liver disease in adults BMJ. – 2018 – Т.362. С.27-34.
